2021 GLOBAL FINALIST

Genetika+

Digital Health Female Founder

Genetika+ is developing groundbreaking technology to tackle the existing and rising anxiety and depression epidemic resulting from COVID-19. The company’s precision medicine technology changes the way to predict drug response for each patient to help patients find their best medication, faster and with better outcomes.

💸 Select investors: GreyBird Ventures, Sapir Venture Partners, Meron Capital, Jumpspeed Ventures, MassChallenge, Michael Zeisser

📌 HQ: Jerusalem, Israel

🔗 https://www.genetikaplus.com/

🔗 Crunchbase